UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.773

Sortiert nach

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

Radiology, 2012-05, Vol.263 (2), p.344

Jack, Jr, Clifford R

2012

Volltextzugriff (PDF)

The clinical use of structural MRI in Alzheimer disease

Nature reviews. Neurology, 2010-02, Vol.6 (2), p.67

2010

Volltextzugriff (PDF)

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Lancet neurology, 2013-02, Vol.12 (2), p.207-216

2013

Volltextzugriff (PDF)

Testing the right target and right drug at the right stage

Science translational medicine, 2011-11, Vol.3 (111), p.111cm33

2011

Volltextzugriff (PDF)

Non-stationarity in the "resting brain's" modular architecture

PloS one, 2012-06, Vol.7 (6), p.e39731-e39731

2012

Volltextzugriff (PDF)

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Alzheimer's & dementia, 2017-04, Vol.13 (4), p.e1-e85

2017

Volltextzugriff (PDF)

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography

Journal of magnetic resonance imaging, 2011-09, Vol.34 (3), p.494-498

2011

Volltextzugriff (PDF)

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Alzheimer's & dementia, 2017-03, Vol.13 (3), p.205-216

2017

Volltextzugriff (PDF)

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Lancet neurology, 2012-10, Vol.11 (10), p.868-877

2012

Volltextzugriff (PDF)

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Lancet neurology, 2017-06, Vol.16 (6), p.435-444

2017

Volltextzugriff (PDF)

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Lancet neurology, 2010, Vol.9 (1), p.119-128

2010

Volltextzugriff (PDF)

The transformative potential of plasma phosphorylated tau

Lancet neurology, 2020-05, Vol.19 (5), p.373-374

Jack, Clifford R

2020

Volltextzugriff (PDF)

Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward

Lancet neurology, 2024-02, Vol.23 (2), p.129-130

Jack, Clifford R

2024

Volltextzugriff (PDF)

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & dementia, 2011-05, Vol.7 (3), p.257-262

2011

Volltextzugriff (PDF)

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

Alzheimer's & dementia, 2017-05, Vol.13 (5), p.561-571

2017

Volltextzugriff (PDF)

A Bayesian Approach to Multistate Hidden Markov Models: Application to Dementia Progression

Journal of the American Statistical Association, 2020-01, Vol.115 (529), p.16-31

2020

Volltextzugriff (PDF)

Preclinical Alzheimer's disease: a valid concept

Lancet neurology, 2020-01, Vol.19 (1), p.31-31

Jack, Clifford R

2020

Volltextzugriff (PDF)

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

Lancet neurology, 2014-10, Vol.13 (10), p.997-1005

2014

Volltextzugriff (PDF)

Performance of plasma phosphorylated tau 181 and 217 in the community

Nature medicine, 2022-07, Vol.28 (7), p.1398-1405

2022

Volltextzugriff (PDF)

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

NeuroImage clinical, 2016-01, Vol.11 (C), p.802-812

2016

Volltextzugriff (PDF)

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Neurology, 2023-11, Vol.101 (19), p.e1837

2023

Volltextzugriff (PDF)

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & dementia, 2011-05, Vol.7 (3), p.263-269

2011

Volltextzugriff (PDF)

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)

Diabetes care, 2017-11, Vol.40 (11), p.1514-1521

2017

Volltextzugriff (PDF)

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Movement disorders, 2017-01, Vol.32 (1), p.124-133

2017

Volltextzugriff (PDF)

1 – 25 von 1.773

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Journals

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.702)
Mit Volltextzugriff
(1.540)

Publikationsform

Sprache

Englisch
(1.773)
Japanisch
(176)
Norwegisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

The clinical use of structural MRI in Alzheimer disease

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Testing the right target and right drug at the right stage

Non-stationarity in the "resting brain's" modular architecture

Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The transformative potential of plasma phosphorylated tau

Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

A Bayesian Approach to Multistate Hidden Markov Models: Application to Dementia Progression

Preclinical Alzheimer's disease: a valid concept

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

Performance of plasma phosphorylated tau 181 and 217 in the community

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Aktive Filter

Suchergebnisse filtern